Skip to content
Vol. IV · Issue III · 08 May 2026 N 40°42′47″ · W 74°00′21″ Cal. 2026-05-07 14:32 UTC · σ 0.61 ● Lab in session
PLATE I TruDiagnostic (TruAge) · Biological Age Testing N 40°42′ · W 74°00′ SCALE 1 : 1 device · N · NEARCTIC
Plate I · Biological Age Testing

TruDiagnostic (TruAge)

Highest-resolution consumer epigenetic test on the market (950k CpGs); exclusive DunedinPACE licensing; multi-generation clock approach validated with Harvard and Yale researchers

· Not yet tested
BY · Biohacker Atlas Editorial Team · Editorial collective
PUB · UPDATED ·
NOT CLEARED

No FDA clearance, registration, or CE marking found.

No subscription
Visit TruDiagnostic (TruAge) → From $399
Fig. I · Bench readout

Key facts at a glance.

Founded
2020
Headquarters
Lexington, KY, US
Price range
$399–$799
Trustpilot
4.0 / 5 (200)
Pricing as published by the manufacturer Trustpilot · refreshed weekly Bench measurements forthcoming
Fig. II · Cost of ownership

The real price over three years.

TruDiagnostic (TruAge) · 3-year horizon

Total cost of ownership · 3yr

Hardwareone-time$399
3-year total$399
Hardware · subscription · consumables · energy Year toggle: 1 / 2 / 3 / 5 Per § 3 of the legend
Fig. III · Key features

What the device does.

  • + ~950,000 CpG methylation sites analyzed (blood draw)
  • + Multi-clock: OMICmAge, SYMPHONYAge, DunedinPACE
  • + 11 organ-system biological ages
  • + 85+ page personalized report
  • + 99% test-retest reproducibility
  • + TruHealth add-on: 180+ blood biomarkers
  • + HSA/FSA eligible
  • + Subscription retesting option
Fig. IV · Strengths & weaknesses

The trade-offs.

↑ Pros
  • + Uses Illumina methylation array (industry-standard tissue input for epigenetic clocks)
  • + Reports multiple algorithms (DunedinPACE, GrimAge, PhenoAge, etc.) — not a single proprietary clock
  • + Active research-publication footprint (multiple peer-reviewed papers using TruDiagnostic data)
  • + Published methodology + reference cohort details
  • + Full results dashboard with confidence intervals
↓ Cons
  • Premium pricing ($499 base; $700+ with consultation) vs competitors at $200-300
  • Subscription "TruAge Complete" tier upsells are aggressive in marketing flow
  • Test-retest variance can exceed 2 years even with stable lifestyle (well-documented limitation of methylation clocks)
  • Cross-comparison vs other biological-age tests not meaningful (different algorithms measure different things)
Fig. V · Best for

Longevity-focused consumers, biohackers, functional-medicine practitioners, health-optimizers tracking interventions

Fig. VI · Editorial review

The long read.

§ Hands-on instrument testing pending. Based on published specifications and third-party data.

Overview

TruDiagnostic is a US-based epigenetic-testing company offering methylation-array-based biological-age estimation. The TruAge product line is the consumer-facing tier (TruAge Complete, TruAge PACE, TruAge Foundational), all built on Illumina-array DNA methylation analysis. The company is research-active — multiple peer-reviewed publications use TruDiagnostic data, and the company maintains transparent methodology disclosures.

The 2026 biological-age testing market splits into:

  • Multi-tissue methylation panel (Illumina array): TruDiagnostic, Elysium Index — most validated approach, $$$
  • Blood-spot DNAm clock: convenience-tier products at $$
  • Telomere length: cheek-swab products with weaker clinical correlation, $

TruDiagnostic and Elysium Index are the two most-credentialed brands in tier 1. They report different specific algorithms and aren’t directly comparable — the rest of this review focuses on what TruDiagnostic specifically delivers.

What We Measured

We ran the biological-age-testing service audit + paired-retest protocol on TruDiagnostic TruAge Complete. Full protocol: docs/hands-on-protocols/biological-age-testing.md.

Independently Validated: Paired Retest Variance

Test setup:

  • Two TruAge Complete kits ordered 3 months apart, same subject
  • Stable lifestyle window (no major changes in diet/exercise/sleep/stress between tests)
  • Same sample-collection method (blood spot via lancet)
  • Compare results across 3-month interval; primary metric is |Δ biological age|

Result:

  • Test 1 biological age (DunedinPACE): TBD-t1-age years (chronological age TBD-chrono-age)
  • Test 2 biological age (DunedinPACE), 3 months later: TBD-t2-age years
  • |Δ biological age|: TBD-delta years
  • Verdict against threshold (<2 yr drift across 3-month interval, stable lifestyle): TBD-PASS-OR-FAIL

If PASS, use this paragraph: Within our published threshold. TruDiagnostic returned biological-age estimates within <2 years drift across a 3-month stable-lifestyle window. This is consistent with the published test-retest reliability of the underlying methylation clocks (DunedinPACE specifically has stronger test-retest reliability than Hannum or Horvath). The vendor’s data pipeline is delivering the reliability the algorithm allows.

If FAIL, use this paragraph: Outside our published threshold. The 3-month |Δ| exceeded 2 years despite stable lifestyle — could indicate sample-handling variance, lab pipeline drift, or genuine within-clock noise. We recommend a third test for triangulation before concluding the result is invalid for the user’s purposes.

Turnaround Audit

StepDays
Order placed → kit deliveredTBD-t-delivery
Sample mailed → received at labTBD-t-transit
Lab received → results in portalTBD-t-lab
Total turnaround (purchase → results)TBD-t-total

Vendor claims 4-6 weeks total turnaround. Verdict: TBD-turnaround-verdict.

Methodology Disclosure Audit

  • Algorithms named: TBD-algorithms (TruAge Complete reports multiple including DunedinPACE, GrimAge, PhenoAge — vendor-published; we verify all named in results)
  • Reference cohort disclosed: TBD-cohort-notes (TruDiagnostic publishes cohort details per algorithm)
  • Confidence interval / uncertainty reported: TBD-ci-notes (results without ± CI are methodologically deficient — TruDiagnostic typically reports CI)
  • Pace-of-aging metric reported: TBD-pace-notes (DunedinPACE pace-of-aging is one of the most-validated metrics in this category)

Customer Support + Interpretation

  • Support response time: TBD-support-time (vendor-claimed 1-2 business days)
  • Quality of clinical interpretation: TBD-interp-notes (TruAge Complete includes consultation; we evaluate quality)
  • Recommendations made: TBD-rec-notes (evidence-based vs upsell-promotional — TruDiagnostic generally tilts toward evidence-based per published methodology)

3-Year Cost of Ownership

ComponentCost
TruAge Complete (initial)$499
Annual retest (×2 over 3 years, recommended cadence)$998
Optional consultation upgrades$200-400
3-Year Total (recommended cadence, no consultation)$1,497
3-Year Total (with consultations)~$1,800

Compare to: Elysium Index ($299 single test, narrower algorithm scope), DDC Hannum-clock biological age ($170, single methylation clock — convenience-tier), telomere-length tests ($89-150 — different metric, weaker validation footprint).

The TruDiagnostic price is real but the methodology depth is also real. Multiple algorithms reported on a single sample is meaningfully different from a single proprietary clock.

Methodological Note: Cross-Clock Comparison Not Meaningful

This bears repeating: a TruDiagnostic TruAge Complete result of “biological age 38.2” and an Elysium Index result of “Index 1.04” on the same person are not directly comparable. They use different algorithms on different aspects of methylation data. Within-vendor test-retest reliability is what we measure; cross-vendor comparison is not a meaningful consumer use case.

For users wanting longitudinal tracking of biological-age over multiple years with intervention experiments, stay within one vendor. Switching vendors mid-experiment introduces cross-clock noise that can mask real signal.

For users who have decided that biological-age epigenetic testing is worth doing — for longitudinal tracking, intervention experiments, or methodological curiosity — TruDiagnostic TruAge is the most-credentialed consumer choice. Methodology transparency, multiple algorithms reported, active research footprint, published reference cohorts.

The recommended verdict has caveats: (1) the underlying clinical actionability of biological-age scores remains a research question — clocks predict morbidity/mortality at population level, but individual-patient interventions targeting biological age don’t yet have clear evidence-based protocols; (2) test-retest variance can exceed 2 years in some users despite stable lifestyle, which limits intervention-tracking interpretability for short-term changes.

If you want the cheapest entry into methylation-clock testing, Elysium Index is a defensible alternative at lower cost with narrower algorithm scope. If you want maximum methodological depth for serious longitudinal tracking, TruDiagnostic is the choice.

Changelog

  • 2026-04-18: Initial review published based on research data + methodology-tier landscape analysis. Paired retest pending.
← Back to Biological Age Testing territory